is tirzepatide the same as glp-1 Frontiers Semaglutide vs Tirzepatide, same medication

doi: 10.1093/toxsci/kfaa002

Population-scale studies of incretin response, glucagon receptor sensitivity, central appetite-control variants, lipid handling pathways, energy-expenditure-related loci, muscle-preservation genetics, and the cardiovascular-protection signaling that may explain real-world MACE differences, these literatures exist, they are growing, and they are starting to converge on a set of variants whose effect sizes are large enough to influence the prior distribution from which a clinician chooses a starting molecule

Since doses of BA as low as 1.6 gday 1 lead to increases in muscle carnosine content (46), the likelihood that BA supplementation at these doses do indeed saturate these transaminating enzymes is high

2025;17(9):e92454

This makes it an excellent option for individuals with type 2 diabetes who are at higher risk for cardiovascular complications